TrianglePUBLICATIONS · 11468148
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2001 Aug 1
- First author
- Stone RM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Stone RM
- type
- Author
- name
- Berg DT
- type
- Author
- name
- George SL
- type
- Author
- name
- Dodge RK
- type
- Author
- name
- Paciucci PA
- type
- Author
- name
- Schulman PP
- type
- Author
- name
- Lee EJ
- type
- Author
- name
- Moore JO
- type
- Author
- name
- Powell BL
- type
- Author
- name
- Baer MR
- type
- Author
- name
- Bloomfield CD
- type
- Author
- name
- Schiffer CA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Stone RM
- type
- Author
- name
- Berg DT
- type
- Author
- name
- George SL
- type
- Author
- name
- Dodge RK
- type
- Author
- name
- Paciucci PA
- type
- Author
- name
- Schulman PP
- type
- Author
- name
- Lee EJ
- type
- Author
- name
- Moore JO
- type
- Author
- name
- Powell BL
- type
- Author
- name
- Baer MR
- type
- Author
- name
- Bloomfield CD
- type
- Author
- name
- Schiffer CA
- type
- Author
- bibliography ids
- nci-bib-fd1a8a6988d1ad98449302e5
- book metadata
- content sha256
- e29c1da56dc19bb21bc21cfce74ca74bd38fb3a0f2d7192d131ddd1acfbbb9af
- document type
- citation
- dois
- 10.1182/blood.v98.3.548
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11468148
- immutable id
- pubmed:11468148@e29c1da56dc19bb21bc21cfce74ca74bd38fb3a0f2d7192d131ddd1acfbbb9af
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 3
- name
- Blood
- nlm unique id
- 7603509
- pages
- 548-53
- volume
- 98
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11468148
- provenance
- batch id
- bc1299bcdb6a81bdf655
- provider
- NCBI PubMed ESummary
- record sha256
- b0c8e0e0c886be069c9ecb10fdc261232dd0c0bc31a76038fa7828119f9d2cb1
- response sha256
- c4d63e9a162706394efcc7d20cd416503379c383137f167684654db2709afc4f
- retrieved at
- 2026-09-09T23:45:42.126507+00:00
- publication date
- display
- 2001 Aug 1
- precision
- day
- year
- 2001
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
Preserved source evidence · Not medical advice